Changes in behavior as side effects in methylphenidate treatment: review of the literature

References

• BrittonGBCognitive and emotional behavioral changes associated with methylphenidate treatment: a review of preclinical studiesInt J Neuropsychopharmacol2012151415321439107
   PubMed Web of Science ®Google Scholar
• CarlezonWAMagueSDAndersenSLEnduring behavioral effects of early exposure to methylphenidate in ratsBiol Psychiatry200354121330133714675796
   PubMed Web of Science ®Google Scholar
• BolañosCABarrotMBertonOWallace-BlackDNestlerEJMethylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthoodBiol Psychiatry200354121317132914675795
   PubMed Web of Science ®Google Scholar
• VolkowNDWangGJFowlerJSDopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidateAm J Psychiatry199815510132513319766762
   PubMed Web of Science ®Google Scholar
• WangGJVolkowNDWigalTLong-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorderPLoS One20138516
   Web of Science ®Google Scholar
• AdvokatCWhat are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD)Neurosci Biobehav Rev20103481256126620381522
   PubMed Web of Science ®Google Scholar
• StorebøOJRamstadEKroghHBMethylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Cochrane Database Syst Rev201511CD00988526599576
   PubMedGoogle Scholar
• ReicheDRoche Lexikon Medizin [Medical Encyclopedia]4th edMunichUrban & Fischer2003
   Google Scholar
• ChallmanTLipskyJJMethylphenidate: its pharmacology and usesMayo Clin Proc200075771172110907387
   PubMed Web of Science ®Google Scholar
• KuczenskiRSegalDEffects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamineJ Neurochem1997685203220379109529
   PubMed Web of Science ®Google Scholar
• GatleySJPanDChenRChaturvediGDingYSAffinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transportersLife Sci199658122312398786705
   PubMed Web of Science ®Google Scholar
• GrayJDPunsoniMTaboriNEMethylphenidate administration to juvenile rats alters brain areas involved in cognition, motivated behaviors, appetite, and stressJ Neurosci200727277196720717611273
   PubMed Web of Science ®Google Scholar
• Germany Federal Ministry of HealthBekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über eine Änderung der Arzneimittel-Richtlinie [Declaration of a resolution of the Federal Joint Committee about a modification of the guideline for medicine]BerlinBundesministerium für Gesundheit2010
   Google Scholar
• SilvaRRMunizRPestreichLEfficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorderJ Child Adolesc Psychopharmacol200616323925116768632
   PubMed Web of Science ®Google Scholar
• BronTIBijlengaDBoonstraAMOROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over studyEur Neuropsychopharmacol201424451952824508533
   PubMed Web of Science ®Google Scholar
• GhumanJKGinsburgGSSubramaniamGHumanHSKauASRiddleMAPsychostimulants in preschool children with attention-deficit/hyperactivity disorder: clinical evidence from a developmental disorders institutionJ Am Acad Child Adolesc Psychiatry200140551652411349695
   PubMed Web of Science ®Google Scholar
• MaayanLPaykinaNFriedJStraussTGuggaSSGreenhillLThe open-label treatment of attention-deficit/hyperactivity disorder in 4- and 5-year-old children with beaded methylphenidateJ Child Adolesc Psychopharmacol200919214715319374023
   PubMed Web of Science ®Google Scholar
• BarbaresiWJKatusicSKColliganRCWeaverALLeibsonCLJacobsenSJLong-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based studyJ Dev Behav Pediatr200627111016511362
   PubMed Web of Science ®Google Scholar
• SmithGJongelingBHartmannPRaine ADHD Study: Long-Term Outcomes Associated with Stimulant Medication in the Treatment of ADHD in ChildrenPerthGovernment of Western Australia Department of Health2010
   Google Scholar
• AagaardLHansenEHThe occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studiesNeuropsychiatr Dis Treat2011772974422247615
   PubMed Web of Science ®Google Scholar
• BiedermanJQuinnDWeissMEfficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorderPaediatr Drugs200351283384114658924
   PubMedGoogle Scholar
• ArabgolFPanaghiLHebraniPReboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorderEur Child Adolesc Psychiatry2009181535918563471
   PubMed Web of Science ®Google Scholar
• AmiriSMohammadiMRMohammadiMNeuroozinejadGHKahbaziMAkhondzadehSModafinil as a treatment for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized clinical trialProg Neuropsychopharmacol Biol Psychiatry200832114514917765380
   PubMed Web of Science ®Google Scholar
• FindlingRLQuinnDHatchSJCameronSJDeCoryHHMcDowellMComparison of the clinical efficacy of twice-daily Ritalin and once-daily Equasym XL with placebo in children with attention deficit/hyperactivity disorderEur Child Adolesc Psychiatry200615845045916791541
   PubMed Web of Science ®Google Scholar
• NewcornJHKratochvilCJAllenAJAtomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential responseAm J Psychiatry2008165672173018281409
   PubMed Web of Science ®Google Scholar
• GreenhillLMunizRBallRRLevineAPestreichLJiangHEfficacy and safety of dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry200645781782316832318
   PubMed Web of Science ®Google Scholar
• GauSSShenHYSoongWTGauCSAn open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in TaiwanJ Child Adolesc Psychopharmacol200616444145516958569
   PubMed Web of Science ®Google Scholar
• KemnerJEStarrHLCicconePEHooper-WoodCGCrockettRSOutcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective studyAdv Ther200522549851216418159
   PubMed Web of Science ®Google Scholar
• SwansonJMWigalSBWigalTA comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the COMACS study)Pediatrics20041133 Pt 1e206e21614993578
   PubMed Web of Science ®Google Scholar
• KratochvilCJHeiligensteinJHDittmannRAtomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trialJ Am Acad Child Adolesc Psychiatry200241777678412108801
   PubMed Web of Science ®Google Scholar
• AdlerLAOrmanCStarrHLLong-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year studyJ Clin Psychopharmacol201131110811421192153
   PubMed Web of Science ®Google Scholar
• BuitelaarJKRamos-QuirogaACasasMSafety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorderNeuropsychiatr Dis Treat2009545746619777067
   PubMed Web of Science ®Google Scholar
• CasasMRöslerMKooijJJEfficacy and safety of prolonged- release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: a 13-week, randomized, double-blind, placebo-controlled, fixed-dose studyWorld J Biol Psychiatry201314426828122106853
   PubMed Web of Science ®Google Scholar
• The MTA Cooperative GroupA 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorderArch Gen Psychiatry199956121073108610591283
   PubMed Web of Science ®Google Scholar
• ArnoldLEHowardBACantwellDPNational Institute of Mental Health collaborative multimodal treatment study of children with ADHD (the MTA)Arch Gen Psychiatry19975498658709294378
   PubMed Web of Science ®Google Scholar
• MTA Cooperative GroupNational Institute of Mental Health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorderPediatrics2004113475476115060224
   PubMed Web of Science ®Google Scholar
• MTA Cooperative GroupNational Institute of Mental Health multimodal treatment study of ADHD follow-up: changes in effectiveness and growth after the end of treatmentPediatrics2004113476276915060225
   PubMed Web of Science ®Google Scholar
• JensenPSArnoldLESwansonJM3-Year follow-up of the NIMH MTA studyJ Am Acad Child Adolesc Psychiatry2007689891002
   Web of Science ®Google Scholar
• MolinaBSHinshawSPSwansonJMThe MTA at 8 years: prospective follow-up of children treated for combined type ADHD in a multisite studyJ Am Acad Child Adolesc Psychiatry200948548450019318991
   PubMed Web of Science ®Google Scholar
• GreenhillLKollinsSAbikoffHEfficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHDJ Am Acad Child Adolesc Psychiatry200645111284129317023867
   PubMed Web of Science ®Google Scholar
• WigalTGreenhillLChuangSSafety and tolerability of methylphenidate in preschool children with ADHDJ Am Acad Child Adolesc Psychiatry200645111294130317028508
   PubMed Web of Science ®Google Scholar
• RiddleMAYershovaKLazzarettoDThe Preschool Attention- Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-upJ Am Acad Child Adolesc Psychiatry201352326427823452683
   PubMed Web of Science ®Google Scholar
• ZarinaraARMohammadiMRHazratiNVenlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trialHum Psychopharmacol2010257–853053520860068
   PubMed Web of Science ®Google Scholar
• WigalSBNordbrockEAdjeiALChildressAKupperRJGreenhillLEfficacy of methylphenidate hydrochloride extended-release capsules (Aptensio XR) in children and adolescents with attention-deficit/hyperactivity disorder: a phase III, randomized, double-blind studyCNS Drugs201529433134025877989
   PubMed Web of Science ®Google Scholar
• KooijJJBurgerHBoonstraAMVan der LindenPDKalmaLEBuitelaarJKEfficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder: a randomized placebo-controlled double-blind cross-over trialPsychol Med200434697398215554568
   PubMed Web of Science ®Google Scholar
• BarkleyRAMcMurrayMBEdelbrockCSRobbinsKSide effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic-placebo-controlled evaluationPediatrics19908621841922196520
   PubMed Web of Science ®Google Scholar
• EfronDJarmanFBarkerMSide effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trialPediatrics199710046626669310521
   PubMed Web of Science ®Google Scholar
• LeeJGrizenkoNBhatVSengputaSPolotskaiaAJooberRRelation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHDBMC Psychiatry2011117021510895
   PubMed Web of Science ®Google Scholar
• PelhamWEGnagyEMBurrows-MacleanLOnce-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settingsPediatrics20011076E10511389303
   PubMed Web of Science ®Google Scholar
• SteinMASarampoteCSWaldmanIDA dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorderPediatrics20031125e404e41314595084
   PubMed Web of Science ®Google Scholar
• AdlerLASpencerTMcGoughJJJiangHMunizRLong-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHDJ Atten Disord200912544945919218542
   PubMed Web of Science ®Google Scholar
• BejerotSRydénEMArlindeCMTwo-year outcome of treatment with central stimulant medication in adult attention-deficit/hyperactivity disorder: a prospective studyJ Clin Psychiatry201071121590159720584517
   PubMed Web of Science ®Google Scholar
• FredriksenMDahlAAMartinsenEWKlungsoyrOHaavikJPeleikisDEEffectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidityEur Neuropsychopharmacol201424121873188425453480
   PubMed Web of Science ®Google Scholar
• HussMGinsbergYTvedtenTMethylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trialAdv Ther2014311446524371021
   PubMed Web of Science ®Google Scholar
• HussMGinsbergYArngrimTOpen-label dose optimization of methylphenidate modified release long acting (MPH-LA): a post hoc analysis of real-life titration from a 40-week randomized trialClin Drug Investig2014349639649
   Web of Science ®Google Scholar
• DöpfnerMGörtz-DortenABreuerDRothenbergerAAn observational study of once-daily modified release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safetyEur Child Adolesc Psychiatry2011202243255
   Google Scholar
• GargJArunPChavanBSComparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorderIndian Pediatr201451755055425031133
   PubMed Web of Science ®Google Scholar
• HaertlingFMuellerBBilke-HentschOEffectiveness and safety of a long-acting, once-daily, two-phase release formulation of methylphenidate (Ritalin LA) in school children under daily practice conditionsAtten Defic Hyperact Disord20157215716425346231
   PubMedGoogle Scholar
• KarabekirogluKYazganYMDedeogluCCan we predict short-term side effects of methylphenidate immediate-release?Int J Psychiatry Clin Pract2008121485424916497
   PubMed Web of Science ®Google Scholar
• KhajehpiriZMahmoudi-GharaeiJFaghihiTKarimzadehIKhaliliHMohammadiMAdverse reactions of methylphenidate in children with attention deficit-hyperactivity disorder: report from a referral centerJ Res Pharm Pract201534130136
   Google Scholar
• RobbASFindlingRLChildressACBerrySABeldenHWWigalSBEfficacy, safety, and tolerability of a novel methylphenidate extended-release oral suspension (MEROS) in ADHDJ Atten Disord Epub2014529
   PubMed Web of Science ®Google Scholar
• Valdizán-UsónJRCánovas-MartínezADe Lucas-TaracenaMTA response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA studyNeuropsychiatr Dis Treat2013921121823430373
   PubMed Web of Science ®Google Scholar
• CherlandEFitzpatrickRPsychotic side effects of psychostimulants: a 5-year reviewCan J Psychiatry199944881181310566114
   PubMed Web of Science ®Google Scholar
• RamtvedtBEAabechHSSundetKMinimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidateJ Child Adolesc Psychopharmacol201424313013924666268
   PubMed Web of Science ®Google Scholar
• BuitelaarJKTrottGEHofeckerMLong-term efficacy and safety outcomes with OROS-MPH in adults with ADHDInt J Neuropsychopharmacol201215111321798108
   PubMed Web of Science ®Google Scholar
• SteeleMWeissMSwansonJWangJPrinzoRSBinderCEA randomized, controlled, effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorderCan J Clin Pharmacol2006131e50e6216456216
   PubMedGoogle Scholar
• InglisSKCarucciSGarasPProspective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) StudyBMJ Open201664e010433
   Web of Science ®Google Scholar